Breathe easy: improving outcomes in patients with COPD using non-pharmacological and pharmacological therapies. This course offers insight on non-pharmacological and pharmacological therapies based on the GOLD recommendations, as well as, clinical factors to assess a patient’s severity and risk of complications according to the new classification of COPD as defined by the 2011 to the current GOLD recommendations. Subscribers are also shown how they can devise a daily treatment plan that has been shown to improve outcomes for patients with moderate to severe airflow limitation according to the best clinical evidence. We also cover safety issues, short-acting rescue & long-acting maintenance medications and other agents approved by the US FDA for COPD.
Credit Hours: 2.5
Credit Type: CME | CE | NP | PharmD | RT
- Identify the minimum number of hours per day that patients with resting hypoxemia need to wear their oxygen to improve their mortality
- Devise a daily treatment plan that has been shown to improve outcomes for a patient with moderate to severe COPD according to the GOLD recommendations
- Risk stratify patients with COPD according to the GOLD recommendations
- Identify the nonpharmacological therapies of stable COPD that have been proven to improve outcomes